Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid Modulation and Neural Reward Activation in Healthy Adults
NCT04854551Phase 2Completed
- Sponsor
- University of Colorado Denver
- Start
- May 2021
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of naltrexone in alcohol use disorder (AUD) (2 arms), sponsored by University of Colorado Denver. Primary endpoint: Change in Brain Activation to Reward Between Placebo and Active Medication at 1 week. Started May 2021; status: completed.
02
Drugs
naltrexone
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT04854551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04854551.